home / stock / nvmdf / nvmdf news

NVMDF News and Press, Novamind Inc. From 02/09/22

Stock Information
Company Name: Novamind Inc.
Stock Symbol: NVMDF
Market: OTC
Website: novamind.ca/
Menu
NVMDF NVMDF Quote NVMDF Short NVMDF News NVMDF Articles NVMDF Message Board
Get NVMDF Alerts

News, Short Squeeze, Breakout and More Instantly...
NVMDF - Novamind Participates in Alto Neuroscience Phase II Clinical Trial for MDD and PTSD

Clinical trial underway at Novamind's Draper, UT research site TORONTO, ON / ACCESSWIRE / February 9, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce it is ...
NVMDF - Novamind Appoints Prakash Gowd as Chief Operating Officer

TORONTO, ON / ACCESSWIRE / February 8, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that Prakash Gowd has been appointed as the Company's Chief Operating Offi...

NVMDF - Novamind Chosen for End-of-Life Psychedelic Drug Study

Psychedelic mental health company Novamind Inc. (OTCQB: NVMDF) announced it has been selected by the Ketamine Research Foundation (KRF) to host a phase II clinical trial investigating ketamine-assisted psychotherapy (KAP) for adults with life-threatening illness (the “C...

NVMDF - Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients

TORONTO, ON / ACCESSWIRE / February 3, 2022 / Novamind Inc. (CSE:NM | OTCQB:NVMDF | FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it has been selected by the Ketamine Research Foundation (KRF) to host a phase ...
NVMDF - Novamind Announces Closing of CAD$5 Million Private Placement with Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / January 26, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pl...

NVMDF - Novamind Announces CAD$5 Million Private Placement with Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / January 24, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pl...

NVMDF - Novamind to Participate in Citi's Psychedelic Drug Video Call Series

TORONTO, ON / ACCESSWIRE / January 20, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that it will participate in Citi's Psychedelic Drug Video Call Series to be held ...
NVMDF - Novamind Closes Arizona Acquisition

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. TORONTO, ON / ACCESSWIRE / January 18, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novami...

NVMDF - Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder

TORONTO, ON / ACCESSWIRE / January 13, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it will host a phase I randomized clinical trial for adults with opioid use disorde...

NVMDF - Novamind Unveils New Design Concept for Clinics

TORONTO, ON / ACCESSWIRE / January 5, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today unveiled its clinic design concept (the "Design Concept") to accommodate the unique requiremen...
Previous 10 Next 10